Wickham Micro, a portfolio company of Limerston Capital has completed the acquisition of Medical Engineering Technologies (MET), a medical device testing laboratory based in Dover, Kent.
Founded 25 years ago, MET provides design validation testing and comprehensive medical and combination device batch release testing. The business is recognised as a world leading Contract Research Organisation for Needle Injection Systems and pre-filled syringe testing and works with medical device and pharmaceutical companies in over 20 countries across Africa, Asia, Australasia, Europe and the USA.
As part of the acquisition, investment will be directed to supporting the existing team and expanding capabilities in line with customer demands. MET Founder, Mark Turner will take the role of Director, Medical Devices and Mark Hammond who was appointed Wickham Micro’s CEO earlier this year will have oversight of the group.